| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0B | $2.9B | $2.9B | $2.5B | $0.2B | $0.1B | $0.2B | $0.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.6B | $0.5B | $0.5B | $0.6B | $-0.2B | $-0.2B | $-0.1B | $-0.1B |
| Net Income | $0.3B | $0.2B | $0.3B | $0.3B | $-0.1B | $-0.2B | $-0.1B | $-0.1B |
| EPS (Basic) | $7.54 | $6.08 | $6.76 | $8.60 | $-3.49 | $-3.82 | $-2.22 | $-2.07 |
| EPS (Diluted) | $7.53 | $6.07 | $6.74 | $8.55 | $-3.49 | $-3.82 | $-2.22 | $-2.07 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.8B | $5.7B | $5.9B | $6.3B | $6.3B | $5.2B | $4.4B | $4.1B |
| Current Assets | $1.0B | $0.9B | $1.2B | $1.8B | $1.7B | $0.7B | $0.5B | $0.5B |
| Cash & Equivalents | $0.4B | $0.3B | $0.6B | $1.1B | $1.2B | $0.4B | $0.1B | $0.2B |
| Total Liabilities | $5.0B | $4.7B | $4.6B | $4.5B | $4.4B | $3.7B | $2.7B | $2.3B |
| Current Liabilities | $1.7B | $1.1B | $1.1B | $1.1B | $1.0B | $0.6B | $0.7B | $0.6B |
| Stockholders' Equity | $0.4B | $0.7B | $1.0B | $1.6B | $1.6B | $1.3B | $1.5B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.6B | $0.7B | $0.5B | $0.4B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.3B | $-0.3B | $-0.1B | $-0.5B | $-0.6B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $-0.6B | $-0.9B | $-0.5B | $0.4B | $0.4B | $-0.1B | $-0.4B |